Why Great MedTech Doesn’t Get Adopted
Med Tech Gurus
Why do breakthrough medical technologies still fail to get adopted? In this episode of Med Tech Gurus, we sit down with David Neale, Co-Founder and CEO of Argá MedTech, to explore what it really takes to bring a differentiated cardiac technology from concept to clinical adoption. Argá is advancing next-generation pulsed field ablation (PFA) for the treatment of atrial fibrillation, with early data showing 100% procedural success, strong safety, and high lesion durability. But as David explains, great clinical data alone isn’t enough. Drawing on decades of experience in cardiac rhythm...
info_outline
The Diagnostic Odyssey: What Healthcare Gets Wrong About Patients
Med Tech Gurus
What does it really mean to put the patient at the center of healthcare innovation? In this episode of Med Tech Gurus, we sit down with Stephanie Hunter-Banks of Jazz Pharmaceuticals, a leader in medical learning, patient engagement, and rare disease advocacy. But what makes this conversation truly powerful is that Stephanie doesn’t just study the patient journey—she lives it. As a rare disease patient herself, Stephanie brings a deeply personal and professional perspective to how healthcare systems, MedTech companies, and clinicians engage with patients. Her journey—spanning more than...
info_outline
Time Is Lives
Med Tech Gurus
In rare disease, time isn’t money—it’s lives. In this episode of Med Tech Gurus, we sit down with Dr. Rob Freishtat, physician-scientist, former President and Co-Founder of Uncommon Cures, and board member of the Foundation for mRNA Medicines, to explore how clinical trial design is being rewritten for rare and ultra-rare conditions. Traditional randomized, placebo-controlled trials—largely unchanged for decades—are often too rigid, too slow, and too burdensome for patients facing life-threatening conditions. Dr. Freishtat shares why adaptive trial designs, natural history cohorts,...
info_outline
The End of ‘See One, Do One, Teach One
Med Tech Gurus
What if the future of surgical training doesn’t happen in the operating room? In this episode of Med Tech Gurus, we sit down with Dr. Danny Goel, orthopedic surgeon, clinical professor at the University of British Columbia, and CEO & co-founder of Precision OS, to explore how virtual reality and AI are transforming surgical education. Today’s training environment is under pressure—reduced clinical hours, increasing procedural complexity, and a relentless focus on operating room efficiency are limiting opportunities for hands-on learning. The traditional “see one, do one, teach...
info_outline
Visibility Is the New Currency
Med Tech Gurus
Great technology doesn’t win—visibility does. In this episode of Med Tech Gurus, we sit down with Lauren Schafer, Founder of Lakehouse Digital Media, to explore why so many MedTech and life sciences companies struggle to gain traction—not because of weak innovation, but because of weak visibility and storytelling. Lauren works with founders and leadership teams to turn expertise into credibility, helping companies show up where investors, clinicians, and decision-makers are actually evaluating solutions. From LinkedIn thought leadership to modern SEO strategies shaped by AI, her approach...
info_outline
Why Telehealth Isn’t Just a Video Call
Med Tech Gurus
Access to care remains one of healthcare’s biggest challenges—especially in physical therapy, where patients often travel hours for a single appointment. In this episode of Med Tech Gurus, we sit down with Dr. Ashok Gupta, founder and CEO of TheraNow, a rapidly growing virtual physical therapy platform that has treated more than 70,000 patients nationwide through a network of over 400 therapists. Ashok’s journey began on the front lines as a physical therapist working in rural communities and VA hospitals, where he repeatedly saw patients abandon treatment simply because access to care...
info_outline
Robots Are Coming to the Cath Lab
Med Tech Gurus
What if the future of interventional cardiology isn’t just better devices—but robotic precision? In this episode of Med Tech Gurus, we sit down with Dr. Philippe Bencteux, founder and president of RoboCath, a pioneering company developing robotic platforms designed to transform cardiovascular and neurovascular interventions. A neuroradiologist turned entrepreneur, Dr. Bencteux launched RoboCath after witnessing how access to specialized vascular expertise can determine whether patients live or die—particularly in hospitals lacking advanced interventional capabilities. His vision: bring...
info_outline
Data Isn’t Strategy
Med Tech Gurus
AI can analyze data faster than any human—but strategy still requires judgment. In this episode of Med Tech Gurus, we sit down with Joe Luminiello, Founder and CEO of RCG Intel, a competitive intelligence firm operating at the intersection of healthcare, biopharma, and AI-driven decision making. With more than 40 years of life sciences leadership experience—including helping launch Takeda’s Canadian business and leading a 650-person commercial organization responsible for over $1B in annual sales—Joe brings a unique perspective on what separates data from real strategic insight. Joe...
info_outline
Why Most Radiology AI Fails
Med Tech Gurus
AI can detect lung nodules in milliseconds—so why hasn’t radiology been transformed? In this episode of Med Tech Gurus, we sit down with Khan Siddiqui, radiologist, serial entrepreneur, and CEO of HOPPR, to unpack why most AI tools in medical imaging struggle to survive beyond pilot studies. Dr. Siddiqui explains that detection isn’t the real problem—workflow is. As imaging volumes surge and radiologist shortages intensify, AI must deliver measurable ROI in time savings, reporting efficiency, and reduced cognitive load. Tools that add clicks or increase reading time simply won’t...
info_outline
Rewriting the Rules of Pediatric Lumbar Puncture
Med Tech Gurus
What if one of pediatrics’ most common emergency procedures hasn’t meaningfully evolved in over a century? In this episode of Med Tech Gurus, we sit down with Bob Cooper, CEO of SMoLTAP, to explore how a simple but powerful positioning innovation is transforming infant lumbar punctures. For decades, pediatric spinal taps have relied on manual restraint, inconsistent positioning, and high failure rates—often leading to repeat attempts, unnecessary hospital admissions, and increased stress for clinicians and families. SMoLTAP’s positioning cradle stabilizes infants in a consistent seated...
info_outlineIn this episode of Med Tech Gurus, we sit down with Dr. Adam S. Arthur, Chief Medical Officer for Medtronic’s Neurovascular business — and one of the most influential voices in modern stroke care. With more than 20 years as a practicing neurosurgeon, clinical researcher, and academic leader, Dr. Arthur has helped redefine standards of care for ischemic stroke, hemorrhagic stroke, carotid disease, and neurovascular innovation worldwide.
Now at Medtronic, he’s leading the charge to translate real-world clinical insight into breakthrough devices that scale — from next-generation thrombectomy tools to new applications for established technologies like Onyx, and a pipeline of neurostimulation, robotics, and endovascular therapies that promise to change what’s possible for brain health.
Dr. Arthur shares powerful lessons from decades of clinical trials, including why “the devil is in the details,” how honest collaboration between physicians and industry accelerates innovation, and why failing fast is often the quickest path to breakthroughs. He also offers an exciting look at the future: remote robotics, closed-loop vagus nerve stimulation, and new ways to reach stroke patients with life-saving precision.
If you care about the future of stroke care, neurovascular devices, or scaling innovation responsibly, this episode delivers a masterclass from one of the field’s true thought leaders.